-
摘要:
目的 探究大连市成年人静息心率(resting heart rate, RHR)与代谢综合征(metabolic syndrome, MS)之间的关系。 方法 选取2015年1月1日-2017年12月31日在辽宁省大连市大连医科大学附属医院体检中心体检的人员作为研究对象,采用χ2检验对不同心率组间MS患病率进行比较。利用二元Logistic回归分析模型分析RHR与MS之间的关系。 结果 共纳入研究对象65 745例,其中男性36 356例,占比55.3%,女性29 389例,占比44.7%。Logistic回归分析模型分析结果表明,在校正年龄、身高、体重后,RHR每增加10次/min,全人群的MS患病风险会增加16%(OR=1.16, 95% CI: 1.13~1.20)。与RHR<70次/min的研究对象相比,RHR≥90次/min的研究对象中男性(OR=1.51, 95% CI: 1.34~1.71)和女性(OR=1.89, 95% CI: 1.49~2.40)都有着更高的MS患病风险;此外,与正常BMI(<24 kg/m2)、正常RHR(<80次/min)的研究对象相比,高BMI且高RHR者中女性(OR=14.87, 95% CI: 11.18~19.77)和男性(OR=6.22, 95% CI: 5.40~7.17) 都有着更高的MS患病风险。 结论 本研究发现,随着RHR的加快,MS的患病率逐渐上升。此外,RHR和BMI结合应用可以增加RHR作为MS标志物的效力,RHR可以与BMI联合作为一个潜在的临床测量指标。 Abstract:Objective Investigate the intrinsic relationship between resting heart rate (RHR) and metabolic syndrome (MS). Methods In this study, people who had physical examination in the Physical Examination Center of Dalian Medical University Affiliated Hospital of Dalian City, Liaoning Province from January 1, 2015 to December 31, 2017 were selected as the study subjects. The prevalence of MS among groups with different heart rates was compared by chi-square test. Binary Logistic regression analysis model was used to analyze the relationship between RHR and MS. Results 65 745 subjects were included in the study, including 36 356 males (55.3%) and 29 389 females(44.7%). Logistic regression analysis showed that after adjusting for age, height and weight, the risk of MS increased by 16% for every 10 increase in RHR per minute (OR=1.16, 95% CI: 1.13-1.20). Compared with subjects with a RHR of < 70 bpm, subjects with a RHR of ≥90 bpm had higher odds of MS: 1.51(OR=1.51, 95% CI: 1.34-1.71) in males and 1.89 (OR=1.89, 95% CI: 1.49-2.40) in females. In addition, compared with subjects with normal body mass index (BMI) (< 24 kg/m2) and normal RHR (< 80 bpm), subjects with high BMI and high RHR had higher odds of MS: 14.87 (OR=14.87, 95% CI: 11.18-19.77) in females and 6.22(OR=6.22, 95% CI: 5.40-7.17) in males. Conclusion In this study, the prevalence of metabolic syndrome was found to increase with increased resting heart rate. In addition, combining RHR and BMI can increase the efficacy of RHR as a marker of metabolic syndrome, and RHR can be combined with BMI as a potential clinical measure indicator. -
Key words:
- Resting heart rate /
- Metabolic syndrome /
- Prevalence rate
-
表 1 2015-2017年大连市成年男性不同的RHR分组水平下的变量特征(x±s)
Table 1. Variable characteristics of adult males in Dalian under different RHR grouping levels from 2015 to 2017 (x±s)
特征 静息心率(次/min) F值 P值 <70
(n=19 232)70~<80
(n=11 280)80~<90
(n=4 259)≥90
(n=1 585)年龄(岁) 47.76±14.13 47.16±14.29 46.91±14.40 47.06±15.07 7.081 <0.001 体格指标 身高(cm) 173.32±6.21 173.44±6.23 173.44±6.13 173.21±6.40 1.453 0.369 体重(kg) 75.74±10.38 76.14±10.55 76.12±10.66 75.66±10.99 4.390 0.019 BMI(kg/m2) 25.19±3.02 25.30±3.13 25.29±3.22 25.20±3.26 3.388 0.031 腰围(cm) 88.48±8.23 89.01±8.39 89.16±8.65 89.11±8.74 14.511 <0.001 SBP(mm Hg) 129.71±15.22 131.16±15.09 132.37±15.13 134.32±15.49 77.653 <0.001 DBP(mm Hg) 78.51±10.41 79.77±10.35 80.55±10.39 81.43±10.36 87.443 <0.001 实验室检查(mmol/L) UA 388.18±81.48 391.25±82.60 390.86±85.62 391.17±86.98 3.816 0.007 FBG 5.92±1.51 6.03±1.68 6.14±1.84 6.25±1.96 39.909 <0.001 TC 4.95±0.92 4.99±0.94 4.99±0.93 5.08±1.05 12.427 <0.001 TG 1.74±1.38 1.88±1.58 1.92±1.56 2.05±2.56 39.925 <0.001 HDL-C 1.21±0.29 1.20±0.28 1.20±0.29 1.21±0.31 4.113 0.002 表 2 2015-2017年大连市成年女性不同的静息心率分组水平下的变量特征(x±s)
Table 2. Variable characteristics of adult famales in Dalian under different RHR grouping levels from 2015 to 2017 (x±s)
特征 静息心率(次/min) F值 P值 <70
(n=14 551)70~<80
(n=9 787)80~<90
(n=3 701)≥90
(n=1 350)年龄(岁) 44.79±13.81 43.61±14.01 42.86±14.11 43.45±15.02 26.641 <0.001 体格指标 身高(cm) 162.60±5.84 162.60±5.79 162.54±5.81 162.64±5.95 0.125 0.880 体重(kg) 61.34±8.84 61.32±8.95 61.44±9.01 61.82±9.60 1.382 0.371 BMI(kg/m2) 23.21±3.19 23.20±3.23 23.25±3.20 23.37±3.39 1.266 0.317 腰围(cm) 79.61±8.73 79.57±8.77 79.61±8.66 80.50±9.16 4.582 0.002 SBP(mm Hg) 122.36±16.48 123.24±16.08 124.47±16.14 126.92±16.42 43.798 <0.001 DBP(mm Hg) 72.30±10.03 73.48±10.00 74.32±9.88 75.58±10.22 81.957 <0.001 实验室检查(mmol/L) UA 280.06±62.90 279.37±63.24 281.18±66.24 281.55±65.94 0.988 0.395 FBG 5.46±1.04 5.50±1.10 5.57±1.28 5.71±1.41 28.527 <0.001 TC 4.99±0.98 4.97±0.99 4.94±0.97 5.01±0.98 3.626 0.006 TG 1.24±0.81 1.27±0.84 1.31±0.81 1.31±0.78 10.105 <0.001 HDL-C 1.47±0.32 1.47±0.32 1.46±0.31 1.47±0.31 3.043 0.050 表 3 2015-2017年大连市成年人不同RHR分组对代谢综合征患病风险的影响模型分析结果[OR(95% CI)]
Table 3. Model analysis of the influence of different RHR groups on metabolic syndrome risk factors in Dalian adults from 2015 to 2017 [OR (95% CI)]
静息心率(次/min) 总体组 男性组 女性组 模型1 模型2 模型1 模型2 模型1 模型2 < 70 1.00 1.00 1.00 1.00 1.00 1.00 70~<80 1.13(1.08~1.19) a 1.19(1.13~1.25) a 1.23(1.17~1.30) a 1.22(1.15~1.30) a 1.08(0.95~1.22) 1.13(0.99~1.29) 80~<90 1.27(1.19~1.35) a 1.36(1.27~1.46) a 1.37(1.27~1.48) a 1.38(1.27~1.49) a 1.32(1.12~1.55) a 1.45(1.21~1.73) a ≥90 1.42(1.29~1.57) a 1.55(1.39~1.72) a 1.46(1.30~1.64) a 1.51(1.34~1.71) a 1.86(1.49~2.31) a 1.89(1.49~2.40) a 每增加10 1.13(1.10~1.15) a 1.16(1.13~1.20) a 1.16(1.13~1.19) a 1.17(1.13~1.20) a 1.19(1.12~1.26) a 1.22(1.14~1.30) a 注:a P<0.05。 -
[1] Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome[J]. Lancet, 2005, 365(9468): 1415-1428. DOI: 10.1016/S0140-6736(05)66378-7. [2] Ford ES. Prevalence of the metabolic syndrome in US populations[J]. Endocrinol Metab Clin North Am, 2004, 33(2): 333-350. DOI: 10.1016/j.ecl.2004.03.004. [3] Diaz A, Bourassa MG, Guertin MC, et al. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease[J]. Eur Heart J, 2005, 26(10): 967-974. DOI: 10.1093/eurheartj/ehi190. [4] Saxena A, Minton D, Lee DC, et al. Protective role of resting heart rate on all-cause and cardiovascular disease mortality[J]. Mayo Clin Proc, 2013, 88(12): 1420-1426. DOI: 10.1016/j.mayocp.2013.09.011. [5] Beddhu S, Nigwekar SU, Ma X, et al. Associations of resting heart rate with insulin resistance, cardiovascular events and mortality in chronic kidney disease[J]. Nephrol Dial Transplant, 2009, 24(8): 2482-2488. DOI: 10.1093/ndt/gfp057. [6] 诸骏仁, 高润霖, 赵水平, 等. 中国成人血脂异常防治指南(2016年修订版)[J]. 中国循环杂志, 2016, 31(10): 937-953. DOI: 10.3969/j.issn.1000-3614.2016.10.001.Zhu JR, Gao RL, Zhao SP, et al. Guidelines for prevention and treatment of dyslipidemia in Chinese adults (2016 revised edition)[J]. Chinese Circulation Journal, 2016, 31(10): 937-953. DOI: 10.3969/j.issn.1000-3614.2016.10.001. [7] Grundy SM. Pre-diabetes, metabolic syndrome, and cardiovascular risk[J]. J Am Coll Cardiol, 2012, 59(7): 635-643. DOI: 10.1016/j.jacc.2011.08.080. [8] Perlini S, Naditch-Brule L, Farsang C, et al. Pulse pressure and heart rate in patients with metabolic syndrome across Europe: insights from the GOOD survey[J]. J Hum Hypertens, 2013, 27(7): 412-416. DOI: 10.1038/jhh.2012.61. [9] Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis[J]. J Am Coll Cardiol, 2010, 56(14): 1113-1132. DOI: 10.1016/j.jacc.2010.050.034. [10] Arnold SV, Lipska KJ, Li Y, et al. The reliability and prognosis of in-hospital diagnosis of metabolic syndrome in the setting of acute myocardial infarction[J]. J Am Coll Cardiol, 2013, 62(8): 704-708. DOI: 10.1016/j.jacc.2013.02.062. [11] Kannel WB, Kannel C, Paffenbarger RS Jr, et al. Heart rate and cardiovascular mortality: the Framingham Study[J]. Am Heart J, 1987, 113(6): 1489-1494. DOI: 10.1016/0002-8703(87)90666-1. [12] Aune D, Sen A, ó'hartaigh B, et al. Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality - a systematic review and dose-response meta-analysis of prospective studies[J]. Nutr Metab Cardiovasc Dis, 2017, 27(6): 504-517. DOI: 10.1016/j.numecd.2017.04.004. [13] Inoue T, Iseki K, Iseki C, et al. Higher heart rate predicts the risk of developing hypertension in a normotensive screened cohort[J]. Circ J, 2007, 71(11): 1755-1760. DOI: 10.1253/circj.71.1755. [14] Shigetoh Y, Adachi H, Yamagishi S, et al. Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population[J]. Am J Hypertens, 2009, 22(2): 151-155. DOI: 10.1038/ajh.2008.331. [15] Rogowski O, Steinvil A, Berliner S, et al. Elevated resting heart rate is associated with the metabolic syndrome[J]. Cardiovasc Diabetol, 2009, 8: 55. DOI: 10.1186/1475-2840-8-55. [16] Quan HL, Blizzard CL, Sharman JE, et al. Resting heart rate and the association of physical fitness with carotid artery stiffness[J]. Am J Hypertens, 2014, 27(1): 65-71. DOI: 10.1093/ajh/hpt161. [17] 韩成义, 罗新萍, 张明, 等. 静息心率与代谢综合征关系的队列研究[J]. 中华流行病学杂志, 2016, 37(12): 1653-1657. DOI: 10.3760/cma.j.issn.0254-6450.2016.12.019.Han CY, Luo XP, Zhang M, et al. Association between resting heart rate and metabolic ssyndrome: a cohort study[J]. Chin J Epidemiol, 2016, 37(12): 1653-1657. DOI: 10.3760/cma.j.issn.0254-6450.2016.12.019. [18] Oda E, Aizawa Y. Resting heart rate predicts metabolic syndrome in apparently healthy non-obese Japanese men[J]. Acta Diabetol, 2014, 51(1): 85-90. DOI: 10.1007/s00592-013-0503-9.